Zolbetuximab – September 2025

• Brand names:
  • Vyloy®
• Pharmaceutical Company:
  • ASTELLAS PHARMA AUSTRALIA PTY LTD
• Condition/Indication: Gastric or gastroesophageal junction (G/GOJ) cancer
• Meeting Date: September 2025
• Public Summary Document (PSD) March 2025 September 2025 PBAC Meetings - (PDF 1.2MB)
• Public Summary Document (PSD) March 2025 September 2025 PBAC Meetings - (Word 900KB)

Related Public Summary Documents

• Zolbetuximab – March 2025